-
THE ECONOMIC BURDEN ON FAMILIES OF CHILDREN WITH TYPE 1 SPINAL MUSCULAR ATROPHY IN BRAZIL
Mar 18, 2026, 21:38 PM -
PROVISIONAL PRICING IN MEDICINE POLICY: GLOBAL BENCHMARKING
Mar 18, 2026, 21:38 PM -
IMPACT OF MEDICATION CLUSTERS ON POST-DISCHARGE ADVERSE DRUG EVENTS AND HEALTHCARE UTILIZATION AMONG OLDER ADULTS
Mar 18, 2026, 21:38 PM -
PREDICTING PROSTATE CANCER INCIDENCE USING A LARGE, NATIONAL U.S. ELECTRONIC HEALTH RECORDS (EHR) DATABASE
Mar 18, 2026, 21:38 PM -
EPIDEMIOLOGY AND TREATMENT PATTERNS OF THRYOID EYE DISEASE IN SPAIN: POPULATION-BASED REAL-WORLD EVIDENCE
Mar 18, 2026, 21:38 PM -
TRANSPARENCY OF CHARLSON COMORBIDITY INDEX (CCI) CODE DEFINITIONS IN REAL-WORLD RESEARCH: A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
RESPONDING TO PUBLIC HEALTH CRISES: COMMUNITY PHARMACISTS' ESSENTIAL CONTRIBUTIONS
Mar 18, 2026, 21:38 PM -
A COST-UTILITY ANALYSIS OF TOCILIZUMAB PLUS METHOTREXATE VERSUS METHOTREXATE ALONEIN RHEUMATOID ARTHRITIS IN INDIA, USING THE MARKOV STATE TRANSITION MODEL
Mar 18, 2026, 21:38 PM -
IMPACT OF COMORBIDITIES ON SELF-REPORTED QUALITY-OF-LIFE IN US ADULTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A POOLED ANALYSIS OF THE 2016-2022 MEDICAL EXPENDITURE PANEL SURVEY (MEPS)
Mar 18, 2026, 21:38 PM -
CYP2D6-GUIDED OPIOID PRESCRIBING AND CLINICAL OUTCOMES IN CHRONIC PAIN: EVIDENCE FROM THE ADOPT PGX TRIAL LINKED TO MEDICARE AND MEDICAID CLAIMS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF SILVER-CONTAINING DRESSING IN PATIENTS WITH DIABETIC FOOT ULCERS IN KOREA
Mar 18, 2026, 21:38 PM -
DO DISPARITIES IN SURGICAL REFERRALS INDICATE PREJUDICE? EVIDENCE FROM A PHYSICIAN SITUATIONAL CHOICE EXPERIMENT
Mar 18, 2026, 21:38 PM -
SOCIAL MEDIA CONVERSATIONS ON IMMUNE CHECKPOINT INHIBITORS: TREATMENT EXPERIENCES, SAFETY, ACCESS, AND PATIENT PERSPECTIVES
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF SINGLE-DOSE HPV VACCINATION IN NEPAL:AN ECONOMIC EVALUATION
Mar 18, 2026, 21:38 PM -
COST-SAVING OUTCOMES OF BIOLOGIC THERAPY OPTIMIZATION IN IMMUNE-MEDIATED SKIN DISEASES
Mar 18, 2026, 21:38 PM -
VALUE SETS FOR AQOL, EQ-5D, HUI, QWB AND SF-6D: A SYSTEMATIC REVIEW OF THEIR AVAILABILITY AND CHARACTERISTICS
Mar 18, 2026, 21:38 PM -
OPERATIONALIZING PATIENT ENGAGEMENT IN RARE DISEASE VALUE RESEARCH LESSONS FROM DISEASE-SPECIFIC USE CASES
Mar 18, 2026, 21:38 PM -
EVALUATING THE QUALITY OF CLINICAL EVIDENCE FOR DIGITAL HEALTH SOLUTIONS ACROSS FIVE THERAPEUTIC AREAS: FINDINGS FROM PHTI ASSESSMENTS
Mar 18, 2026, 21:38 PM -
GENERAL-PURPOSE VS HEOR-SPECIFIC GENERATIVE AI IN RARE DISEASE MODELING: A DUCHENNE MUSCULAR DYSTROPHY CASE STUDY
Mar 18, 2026, 21:38 PM -
UPDATING SYSTEMATIC LITERATURE REVIEWS AND REPORTS USING A GENERATIVE AI-ENABLED FRAMEWORK
Mar 18, 2026, 21:38 PM
